Catheter Ablation vs Drug Therapy for Patients With Atrial Fibrillation: The CABANA Trial

Two reports in JAMA detail findings from the CABANA trial, a randomized, open-label trial comparing the effects of drug therapy vs cardiac catheter ablation on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with symptomatic atrial fibrillation. In this video, JAMA Deputy Editor Gregory Curfman, MD, describes the study and the clinical implications of the results.

Read the 2 CABANA Trial reports at https://ja.ma/2O6WFOf and https://ja.ma/2Hjcelr.
Read the editorial at https://ja.ma/2JdXLJr.
Read the CAPTAF Trail at https://ja.ma/2TINdGh.

Видео Catheter Ablation vs Drug Therapy for Patients With Atrial Fibrillation: The CABANA Trial канала JAMA Network